Avenzo Therapeutics, Inc.
Developing the next generation of oncology therapies for patients.
Funding history
About Avenzo Therapeutics, Inc.
How much funding has Avenzo Therapeutics, Inc. raised?
Avenzo Therapeutics, Inc. has raised $656.4M in total funding.
Where is Avenzo Therapeutics, Inc. headquartered?
Avenzo Therapeutics, Inc. is headquartered in San Diego, CA.
What does Avenzo Therapeutics, Inc. do?
Developing the next generation of oncology therapies for patients.
What problem does Avenzo Therapeutics, Inc. solve?
Cancer patients need better medicines than what's currently available for solid tumors.
What's Avenzo Therapeutics, Inc.'s solution?
Avenzo Therapeutics develops next-generation oncology drug candidates aimed at validated targets in solid tumors, advancing them through a clinical pipeline.
What makes Avenzo Therapeutics, Inc. notable?
Co-founded in 2022 by Athena Countouriotis, who previously led Turning Point Therapeutics, which was acquired by Bristol-Myers Squibb for $4.1 billion in 2022.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.